EMPLOYMENT AGREEMENTEmployment Agreement • May 8th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 8th, 2024 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), dated as of February 24, 2024, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Marella Thorell (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
SUPPLY AGREEMENTSupply Agreement • May 8th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 8th, 2024 Company IndustryTHIS SUPPLY AGREEMENT (the “Agreement”), effective as of September 15, 2015 (the “Effective Date”), is made and entered into by and between Seres Therapeutics, Inc. (formerly Seres Health, Inc.), a corporation organized and existing under the laws of Delaware, having its principal place of business at 215 First Street, Cambridge MA 02142, USA (“Seres”); and GenIbet BioPharmaceuticals, SA, a corporation organized and existing under the laws of Portugal, having its principal place of business at Edifício da Unidade Piloto do IBET, Estação Agronómica Nacional, Avenida da República, 2780-157 Oeiras, Portugal (“GenIbet”). Seres and GenIbet may be referred to herein individually as a “Party” or collectively as the “Parties.”
SERES THERAPEUTICS, INC. ADVISORY AGREEMENTAdvisory Agreement • May 8th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 8th, 2024 Company IndustryTHIS ADVISORY AGREEMENT (this “Agreement”) is made and effective as of March 15, 2024 (the “Effective Date”) by and between David Arkowitz, an individual (“Advisor”), whose address is set forth on the signature page below and SERES THERAPEUTICS, Inc., a Delaware corporation (along with its affiliated companies, the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
Separation Agreement and ReleaseSeparation Agreement • May 8th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 8th, 2024 Company IndustryThis Separation Agreement and Release (“Agreement”) is made by and between David Arkowitz (“Executive”) and Seres Therapeutics, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).